Operose Advisors’s Abiomed Inc ABMD Stock Holding History

Operose Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-53	Closed	-$13K	–	389
2022 Q3	$13K	Hold	53	–	–	0.01%	245
2022 Q2	$13K	Hold	53	–	–	0.01%	222
2022 Q1	$18K	Buy	+53	New	+$16.3K	0.01%	224

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Operose Advisors's ABMD Position: Q4 2022 in Review

Operose Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 53 shares — an estimated $13K sold.

Operose Advisors first reported a position in ABMD in Q1 2022 and held it in 3 quarters. The position peaked at $18K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Operose Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Operose Advisors sold 53 Abiomed Inc shares in Q4 2022, an estimated $13K.
Operose Advisors first reported a position in Abiomed Inc in Q1 2022 and held it in 3 quarters.
Operose Advisors's Abiomed Inc position peaked at $18K in Q1 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Operose Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.